Axitinib Amide

Axitinib Amide
GA01210 - 95%
In stock

Others quantities on request
Specifications
- CAS RN: 319462-41-4
- Purity: 95%
- Mol Formula: C21H16N4OS
- Mol Weight: 372.44
- Tags: Pharmaceutical Reference Substances and Impurities ; Axitinib ;
-
Description
GA01210
Axitinib is a small molecule tyrosine kinase inhibitor developed by Pfizer. It has been shown to significantly inhibit growth of breast cancer in animal (xenograft) models[3] and has shown partial responses in clinical trials with renal cell carcinoma (RCC)[4] and several other tumour types.
We have successfully synthesized standards of the Axitinib. This will be of interest to pharmaceutical companies and analytical labs.
-
Additional information